Five years of pharmaceutical industry funding of patient organisations in Sweden: cross-sectional study of companies, patient organisations and drugs

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

    Ozieranski, P., Csanadi, M., Rickard, E., Tchilingirian, J. & Shai Mulinari, 2019 jun 21, I : JAMA Network Open. 2, 6, s. e196253

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Exposing drug industry funding of UK patient organisations

    Ozieranski, P., Richard, E. & Shai Mulinari, 2019 maj 23, I : BMJ: British Medical Journal. 365, l1806 .

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

    Richard, E., Ozieranski, P. & Shai Mulinari, 2019, I : Health Policy. 123, 12, s. 1244-1250

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2018
  6. Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries

    Fabbri, A., Santos, A. L., Mezinska, S., Shai Mulinari & Mintzes, B., 2018 jun, I : International Journal of Health Policy and Management. 7, 6, s. 504-509 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift